Susquehanna Maintains Positive on BKV, Lowers Price Target to $35

Benzinga Newsdesk www.benzinga.com Negative 79.8%

Neg 79.8% Neu 0% Pos 0%

Susquehanna analyst Biju Perincheril maintains BKV (NYSE:BKV) with a Positive and lowers the price target from $37 to $35.